The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The updated recommendations are pending final approval by the director of the CDC and the Department of Health and Human Services.

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

The U.S. Centers for Disease Control's vaccine advisory committee voted to recommend the single-dose vaccine, Vimkunya, for the prevention chikungunya in 12 years and older traveling to a country ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

A key group of government advisers voted to expand the use of vaccines for a common respiratory illness, providing a boost to ...

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya. COPENHAGEN, Denmark, ...

A two-day meeting of the Advisory Committee on Immunization Practices (ACIP), which was originally scheduled for February but ...

Discover why BVNKF's vaccine innovations, growth catalysts, and compelling valuation after a 52% pullback make it a strong ...